Literature DB >> 8496384

Prospective comparative study of computer programs used for management of warfarin.

L Poller1, D Wright, M Rowlands.   

Abstract

AIMS: To compare the effectiveness of three computerised systems that are currently used for assisting warfarin control in outpatients with the customary dosing method used by experienced medical staff.
METHODS: A pilot randomised study of three systems with a follow up independently randomised study of two of these was made on 186 patients receiving long term treatment or who had recently started warfarin treatment and had been discharged from hospital.
RESULTS: All three computerised systems seemed to give satisfactory control compared with the traditional dosing method. For patients receiving more intensive treatment with an assigned target range of 3.0-4.5 computerised dosage programs achieved significantly better control; the medical staff undertreated such patients almost 50% of the time.
CONCLUSION: Computer based programs can assist outpatient anticoagulant control with warfarin during both early and long term treatment. For most patients the control achieved is as good as that obtained by the customary method of dosing, by experienced clinic doctors, although the latter tend to be too conservative when dosing patients within the intense target range of 3.0 to 4.5 International Normalised Ratio (INR). The computers were significantly more successful in this higher range.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8496384      PMCID: PMC501207          DOI: 10.1136/jcp.46.4.299

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  6 in total

1.  Experience with a computer-assisted anticoagulant clinic.

Authors:  A Kubie; A H James; J Timms; R P Britt
Journal:  Clin Lab Haematol       Date:  1989

2.  Computer dosing in anticoagulant clinics--the way forward?

Authors:  P J Wyld; D West; T H Wilson
Journal:  Clin Lab Haematol       Date:  1988

3.  Computer assisted management of warfarin treatment.

Authors:  R Wilson; A H James
Journal:  Br Med J (Clin Res Ed)       Date:  1984-08-18

4.  Therapeutic control of anticoagulant treatment.

Authors:  B M Duxbury
Journal:  Br Med J (Clin Res Ed)       Date:  1982-03-06

5.  Computer control of anticoagulant dose for therapeutic management.

Authors:  P J Ryan; M Gilbert; P E Rose
Journal:  BMJ       Date:  1989-11-11

6.  Assessment of therapeutic control of anticoagulation.

Authors:  A Copplestone; S Roath
Journal:  Acta Haematol       Date:  1984       Impact factor: 2.195

  6 in total
  30 in total

1.  Computer support for determining drug dose: systematic review and meta-analysis.

Authors:  R Walton; S Dovey; E Harvey; N Freemantle
Journal:  BMJ       Date:  1999-04-10

Review 2.  Anticoagulation in patients with thromboembolic disease.

Authors:  R C Tait
Journal:  Thorax       Date:  2001-09       Impact factor: 9.139

Review 3.  Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Anne Holbrook; Sam Schulman; Daniel M Witt; Per Olav Vandvik; Jason Fish; Michael J Kovacs; Peter J Svensson; David L Veenstra; Mark Crowther; Gordon H Guyatt
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 4.  Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Walter Ageno; Alexander S Gallus; Ann Wittkowsky; Mark Crowther; Elaine M Hylek; Gualtiero Palareti
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

5.  The medical office of the 21st century (MOXXI): effectiveness of computerized decision-making support in reducing inappropriate prescribing in primary care.

Authors:  Robyn Tamblyn; Allen Huang; Robert Perreault; André Jacques; Denis Roy; James Hanley; Peter McLeod; Réjean Laprise
Journal:  CMAJ       Date:  2003-09-16       Impact factor: 8.262

Review 6.  Pharmacogenetics of warfarin: challenges and opportunities.

Authors:  Ming Ta Michael Lee; Teri E Klein
Journal:  J Hum Genet       Date:  2013-05-09       Impact factor: 3.172

7.  Non-nuclear staining of thick tissue sections.

Authors:  S Leech; J S Armstrong; J Kulka; J D Davies
Journal:  J Clin Pathol       Date:  1993-08       Impact factor: 3.411

8.  Managing the increased workload in anticoagulant clinics. Computerised decision support is valuable.

Authors:  D A Fitzmaurice; P E Rose; M Gilbert
Journal:  BMJ       Date:  1996-05-11

Review 9.  Fortnightly review: anticoagulation in heart disease.

Authors:  S M Hardman; M R Cowie
Journal:  BMJ       Date:  1999-01-23

10.  Where should oral anticoagulation monitoring take place?

Authors:  F D Hobbs; D A Fitzmaurice
Journal:  Br J Gen Pract       Date:  1997-08       Impact factor: 5.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.